BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1706652)

  • 1. Interleukin-2 induces corneal neovascularization in A/J mice.
    Epstein RJ; Hendricks RL; Stulting RD
    Cornea; 1990 Oct; 9(4):318-23. PubMed ID: 1706652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal neovascularization induced by stimulated lymphocytes in inbred mice.
    Epstein RJ; Stulting RD
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1505-13. PubMed ID: 2442116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.
    Polverini PJ; Leibovich SJ
    Lab Invest; 1984 Dec; 51(6):635-42. PubMed ID: 6209469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea.
    Kamiya K; Wang M; Uchida S; Amano S; Oshika T; Sakuragawa N; Hori J
    Exp Eye Res; 2005 May; 80(5):671-9. PubMed ID: 15862174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.
    Yu H; Wu J; Li H; Wang Z; Chen X; Tian Y; Yi M; Ji X; Ma J; Huang Q
    Biochem Biophys Res Commun; 2007 Oct; 361(4):946-52. PubMed ID: 17692288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-induced corneal neovascularization: a morphologic assessment.
    Epstein RJ; Hughes WF
    Invest Ophthalmol Vis Sci; 1981 Jul; 21(1 Pt 1):87-94. PubMed ID: 6166585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.
    McKenna SD; Chen F; Lai L; Goldschneider I
    J Immunol; 1998 Mar; 160(5):2272-9. PubMed ID: 9498767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice.
    Proust JJ; Kittur DS; Buchholz MA; Nordin AA
    J Immunol; 1988 Dec; 141(12):4209-16. PubMed ID: 3264308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
    Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
    Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.
    Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B
    Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Huang X; McClellan SA; Barrett RP
    Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
    Dorshkind K
    J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of murine hepatic metastases with lymphokine-activated killer cells expanded in serum-free media and recombinant interleukin 2.
    Lafreniere R; Borkenhagen K; Bryant LD; Huchcroft S
    Cancer Res; 1989 May; 49(9):2409-14. PubMed ID: 2565160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB; Maluish AE; Rossio JL; Schlick E; Onozaki K; Talmadge JE; Procopio AD; Ortaldo JR; Ruscetti FW; Stevenson HC
    J Biol Response Mod; 1986 Feb; 5(1):85-107. PubMed ID: 3514800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.